Catalyst Wire Dossier Catalyst Wire Dossier

Seretide Diskus Inhaler

salmeterol xinafoate / fluticasone propionate · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Seretide Diskus Inhaler, covering 2016-09-15 to 2016-09-15. Get the full timeline:

Most recent: Clinical Trial Update: Study In Airway Physiology In Children SERETIDE DISKUS ® Inhlaer and FLIXOTIDE® Inhaler Are Trademarks of GSK Group of Companies. [Phase 4]

See pricing